Keywords
How to Cite
Abstract
Background: Congenital pneumonia remains a significant cause of morbidity and mortality in neonates worldwide. Early detection is often challenging due to nonspecific clinical symptoms, making the identification of reliable inflammatory markers crucial for timely diagnosis and management. This study aims to investigate the clinical course of congenital pneumonia in neonates and to evaluate the diagnostic value of specific inflammatory markers in predicting disease severity and progression. A prospective observational study was conducted in neonates diagnosed with congenital pneumonia.
References
1. Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390(10104):1770–1780.
2. Jain S, Singh M. Congenital pneumonia in neonates: etiology, clinical features, and management. Indian J Pediatr. 2015;82(10):896–903.
3. Klinger G, Levy I, Sirota L, et al. Early-onset neonatal sepsis: recent trends in incidence and microbiology. Pediatr Infect Dis J. 2016;35(5):529–534.
4. Hofer N, Zacharias E, Müller W, Resch B. Laboratory markers for diagnosis and prediction of neonatal sepsis. J Matern Fetal Neonatal Med. 2012;25(Suppl 1):50–53.
5. Zea-Vera A, Ochoa TJ. Challenges in the diagnosis and management of neonatal pneumonia. Curr Opin Infect Dis. 2015;28(3):235–242.
6. Cordero L, Ayers LW. The role of inflammatory markers in neonatal infections. Clin Perinatol. 2016;43(2):295–308.
7. Dong Y, Speer CP. Late-onset neonatal sepsis: recent developments. Arch Dis Child Fetal Neonatal Ed. 2015;100(3):F257–F263.
8. Polin RA, Papile LA. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129(5):1006–1015.
This work is licensed under a Creative Commons Attribution 4.0 International License.
